Interesting: CBD Showing Promise in Coronavirus Prevention
May 27, 2020 With the world health research community desperately searching for a preventative or a possible vaccine/cure for the novel coronavirus (OPERATION WARP SPEED!), a consortium of university and private researchers up in Canada have uncovered preliminary evidence that cannabis may hold the key in developing a widely available, relatively inexpensive and practical preventative treatment for SARS-CoV2.
According to the official research abstract, the research team believes it has demonstrated that high concentrations of CBD extract can help modulate, or suppress, the transmission of active COVID-19 virus pathogens from the mouth, nose, and lungs into an infected subject.
Quoted directly from the research abstract:
“Working under the HealthCanada research license, we have developed over 800 new Cannabis sativa lines and extracts and hypothesized that high-CBD C. sativa extracts may be used to modulate ACE2 expression in COVID19 target tissues. Screening C. sativa extracts using artificial human 3D models of oral, airway, and intestinal tissues, we identified 13 high CBD C. sativa extracts that modulate ACE2 gene expression and ACE2 protein levels. Our initial data suggest that some C. sativa extract down-regulate serine protease TMPRSS2, another critical protein required for SARS-CoV2 entry into host cells. While our most effective extracts require further large-scale validation, our study is crucial for the future analysis of the effects of medical cannabis on COVID-19. The extracts of our most successful and novel high CBD C. sativa lines, pending further investigation, may become a useful and safe addition to the treatment of COVID-19 as an adjunct therapy. They can be used to develop easy-to-use preventative treatments in the form of mouthwash and throat gargle products for both clinical and at-home use.”
Don’t feel like reading through the research report jargon? Here’s a NY Post write up on the development.
Subscribe to eNewsletter
